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The 
138
As an aggregate, African-lineage ZIKV strains were significantly less susceptible to 139 IFNα restriction than Asian-lineage strains (Fig 2B; p=0 .049); they were also less susceptible to 140 IFNβ, though differences in sensitivity to IFNβ (Fig 2C; 158 levels of IFITM3 than in IFNβ-treated A549 control cells ( Fig 3C) .
159
To assess the effect of IFITM3 expression on ZIKV replication, IFITM3-expressing and 160 control cells were infected with African-lineage isolate MR 766 and Asian-lineage isolate 161 PRVABC59, both of which were found to be especially susceptible to IFN-I. Viral replication 162 was not significantly different in cells expressing IFITM3 than from control cells for either strain 163 (Fig 4A, B) . Importantly, an Influenza A reporter virus was potently restricted in IFITM3-164 expressing cells, while virus-like particles expressing the murine leukemia virus envelope protein 167 Notably, cells expressing IFITM3 continued to have a robust response to IFNβ, with 168 drastic reductions in viral replication for both strains (1.6x10 3 -5.1x10 3 -fold) when compared 169 to infection of untreated control cells (Fig 4A, B) . Taken together, these data suggest that the 170 physiological levels of IFITM3 induced by IFNβ in A549 cells are not sufficient to substantially 171 antagonize ZIKV replication and may explain only a small part of the IFNβ effect in these cells. 187 expression was also knocked out in cells transduced with IFITM3-targeted sgRNAs (Fig S2) . 
213
The finding that African-lineage strains in the panel were more resistant to the effects of 214 IFNα as compared to Asian-lineage strains was counter-intuitive given the fact that it is Asian-215 lineage strains that cause severe neuropathologic outcomes in fetuses, neonates, and adults. 
276
There are several reasons that may explain why the current findings differ from previous 277 studies that have described an important role for IFITM3 in restricting ZIKV. First, we utilized 278 different methods for quantifying ZIKV replication. We measured viral titers by TCID 50 assay in 279 cell supernatants, while previous reports have used ZIKV envelope glycoprotein or double-280 stranded DNA immunofluorescence. These assays capture different aspects of ZIKV replication 281 and could explain some of our divergent findings although based on the proposed mechanism of 282 action of IFITM3 early in the life cycle, this would not be expected to be a major factor.
283 Importantly, we used an MOI of 1 and measured viral replication at 48 hpi, which is consistent 284 with most experiments performed in these previous studies. However, prior studies have used 285 HeLa and MEF cells for some experiments to describe IFITM3-mediated restriction of ZIKV.
286 Others have found that IFITM3-mediated restriction can depend on cell type, raising the 287 interesting possibility that IFITM3 restricts ZIKV infection in some cells but not others [30] . A 288 potentially critical difference that may explain the differences in results is the fact that several of 289 these studies have utilized systems that, in many cases, highly overexpress IFITM3 to levels 290 much higher than seen upon IFN-I induction [28, 29] . Thus, it is quite possible that IFITM3 can 291 restrict infection when present at very high levels, although this may not recapitulate the 292 response to IFN-I, where IFITM3 is not expressed at such high levels. It is also worth noting that 293 ours is the first study to examine IFITM3-mediated restriction of ZIKV using a complete Cas9- 318 and 3.3% FBS was added to the inoculum so that the final concentration of FBS was 2%.
319 Supernatants were collected 4 days post-inoculation, except in the case of the FLR isolate, which 320 gave higher titers when supernatants were collected 5 days post-inoculation. Supernatants were 321 cleared of cellular debris by centrifuging for 10 minutes 300g at 4⁰C, before aliquoting and 322 storage at -80⁰C and viral titers were determined by the TCID 50 assay described below.
323 Experiments were performed with aliquots that had undergone at most two freeze-thaw cycles, 324 which was not found to have any discernible effect on viral titers. (Table S2 ) [48] . Five overlapping amplicons were generated by PCR amplification of cDNA 345 with Q5 ReadyMix (NEB) using a subset of primer pairs (Table S3) 350 Each of the amplicons was then subjected to Sanger sequencing using the primers indicated in 351 Table S2 . Full-length open-reading-frame nucleotide sequences of ZIKV strains in the panel, as
